SpringWorks Therapeutics (NASDAQ:SWTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does SpringWorks Therapeutics (SWTX) operate in?

SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SpringWorks Therapeutics Stock (NASDAQ: SWTX) stock price, news, charts, stock research, profile.

Open	$32.45
Close	$32.51
Volume / Avg.	1.04M / 890.74K
Day Range	$31.82 - $32.80
52 Wk Range	18.00 - 53.92
Market Cap	$2.41B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	22.33%
Days to Cover	19.8

Recent News

SpringWorks Q2 Earnings Beat, Ogsiveo Drives Revenues

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) incurred a loss of 54 cents per share in the second quarter of 2024, which was significantly narrower than the Zacks Consensus Estimate of a loss of $1.12. The company had reported a loss of $1.25 per share in the year-ago quarter.

Zacks

Why SpringWorks Therapeutics Stock (SWTX) Is Nosediving

SpringWorks Therapeutics Inc (NASDAQ: SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing of a publ

Henry Khederian

Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$32.45
Close	$32.51
Volume / Avg.	1.04M / 890.74K
Day Range	$31.82 - $32.80
52 Wk Range	18.00 - 53.92
Market Cap	$2.41B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	22.33%
Days to Cover	19.8

About SpringWorks Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SpringWorks Therapeutics (SWTX) stock?

You can purchase shares of SpringWorks Therapeutics (NASDAQ:SWTX) through any online brokerage.

View our list of the best stock brokerages

Who are SpringWorks Therapeutics (SWTX) competitors?

Other companies in SpringWorks Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Centessa Pharmaceuticals (NASDAQ:CNTA), Agios Pharmaceuticals (NASDAQ:AGIO), Arrowhead Pharma (NASDAQ:ARWR) and ACADIA Pharmaceuticals (NASDAQ:ACAD).

What is the forecast, or price target, for SpringWorks Therapeutics (SWTX) stock?

SpringWorks Therapeutics has a consensus price target of $62.33.

What is the current price for SpringWorks Therapeutics (SWTX)?

The stock price for SpringWorks Therapeutics (NASDAQ: SWTX) is $32.51 last updated September 25, 2024 at 4:00 PM EDT.

Does SpringWorks Therapeutics (SWTX) pay a dividend?

There are no upcoming dividends for SpringWorks Therapeutics.

When is SpringWorks Therapeutics (NASDAQ:SWTX) reporting earnings?

SpringWorks Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is SpringWorks Therapeutics (SWTX) going to split?

There is no upcoming split for SpringWorks Therapeutics.

What sector and industry does SpringWorks Therapeutics (SWTX) operate in?

SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge